Picture2crop.png

THE INCUBATOR

HBI 2018-19


This year, we’re working on developing a novel drug discovery platform aimed at disrupting lncRNA-protein interactions. Our platform has the potential to be applied to a variety of diseases and indications, and could have far-reaching implications.

See our schedule below:


tentative_2018_schedule_hbi.png